Author

Jay Tibbitts

SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES
SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES

Jay Tibbitts  et al.

PHARMACOKINETIC AND NONCLINICAL SAFETY EVALUATION OF SZN-1326, A WNT SIGNAL ACTIVATOR, IN NON-HUMAN PRIMATES
PHARMACOKINETIC AND NONCLINICAL SAFETY EVALUATION OF SZN-1326, A WNT SIGNAL ACTIVATOR, IN NON-HUMAN PRIMATES

Jay Tibbitts  et al.

SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES
SZN-043, AN R-SPONDIN MIMETIC IN DEVELOPMENT FOR THE TREATMENT OF LIVER DISEASE, DEMONSTRATES A STRONG SAFETY PROFILE IN NONCLINICAL TOXICOLOGY STUDIES

PHARMACOKINETIC AND NONCLINICAL SAFETY EVALUATION OF SZN-1326, A WNT SIGNAL ACTIVATOR, IN NON-HUMAN PRIMATES
PHARMACOKINETIC AND NONCLINICAL SAFETY EVALUATION OF SZN-1326, A WNT SIGNAL ACTIVATOR, IN NON-HUMAN PRIMATES

SZN-1326, A TETRAVALENT, BISPECIFIC ANTIBODY DEVELOPED FOR THE TREATMENT OF ULCERATIVE COLITIS, HAS A FAVORABLE PROFILE IN 13-WEEK GLP TOXICITY STUDIES
SZN-1326, A TETRAVALENT, BISPECIFIC ANTIBODY DEVELOPED FOR THE TREATMENT OF ULCERATIVE COLITIS, HAS A FAVORABLE PROFILE IN 13-WEEK GLP TOXICITY STUDIES

Jay Tibbitts  et al.

TRANSCRIPTOME ANALYSIS OF HUMAN LIVERS EXPLANTS FROM ALCOHOL-ASSOCIATED LIVER DISEASES HIGHLIGHTS A LOSS OF PERICENTRAL AND PROLIFERATION GENE EXPRESSION
TRANSCRIPTOME ANALYSIS OF HUMAN LIVERS EXPLANTS FROM ALCOHOL-ASSOCIATED LIVER DISEASES HIGHLIGHTS A LOSS OF PERICENTRAL AND PROLIFERATION GENE EXPRESSION

Jay Tibbitts  et al.

SZN-1326, A WNT MIMETIC, IMPROVED EPITHELIAL HEALING AND DECREASED COLLAGEN DEPOSITION IN A DEXTRAN SULFATE SODIUM-INDUCED COLITIS MOUSE MODEL
SZN-1326, A WNT MIMETIC, IMPROVED EPITHELIAL HEALING AND DECREASED COLLAGEN DEPOSITION IN A DEXTRAN SULFATE SODIUM-INDUCED COLITIS MOUSE MODEL

Jay Tibbitts  et al.

SZN-1326, A WNT SIGNAL ACTIVATOR, IS MORE EFFICACIOUS THAN CYCLOSPORINE A IN AN ACUTE DSS MODEL
SZN-1326, A WNT SIGNAL ACTIVATOR, IS MORE EFFICACIOUS THAN CYCLOSPORINE A IN AN ACUTE DSS MODEL

Jay Tibbitts  et al.

SZN1326, A WNT AGONIST, WAS SUPERIOR TO ANTI-IL12/23P40 AND ANTI-TNF-A ANTIBODIES IN RESTORING EPITHELIAL INTEGRITY AND MITIGATING COLITIS IN A CHRONIC DSS MODEL
SZN1326, A WNT AGONIST, WAS SUPERIOR TO ANTI-IL12/23P40 AND ANTI-TNF-A ANTIBODIES IN RESTORING EPITHELIAL INTEGRITY AND MITIGATING COLITIS IN A CHRONIC DSS MODEL

Jay Tibbitts  et al.

Item 1 - 9 / 9
1